Zoetis Share Price Today
(NASDAQ: ZTS)

Name: Zoetis Share Price Today (NASDAQ: ZTS) - Zoetis Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Zoetis share price is $160.46 & ₹13,916.05 as on 22 Feb 2025, 2.30 'hrs' IST

$160.46

▲

3.04

(1.93%)

Market is closed - opens 8 PM, 24 Feb 2025

View live Zoetis share price in Dollar and Rupees. Guide to invest in Zoetis stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Zoetis, along with analyst recommendations, forecasts, and comprehensive financials.

Zoetis share price movements

Today's Low: $157.60
Today's High: $160.90
$160.46
1.78%
Downside
Day's Volatility :2.05%
Upside
0.27%
52 Weeks Low: $144.80
52 Weeks High: $200.53
$160.46
9.76%
Downside
52 Weeks Volatility :27.79%
Upside
19.98%

Zoetis (ZTS) Returns

Period	Zoetis Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-11.91%	2.2%	0.0%
6 Months	-13.3%	-4.8%	0.0%
1 Year	-20.18%	1.2%	0.0%
3 Years	-15.85%	15.5%	-12.0%

Zoetis (ZTS) Key Statistics

in dollars & INR

Previous Close	$157.42
Open	$157.78
Today's High	$160.9
Today's Low	$157.6
Market Capitalization	$70.5B
Today's Volume	$4.3M
52 Week High	$200.5341
52 Week Low	$144.8
Revenue TTM	$9.3B
EBITDA	$3.8B
Earnings Per Share (EPS)	$5.47
PE Ratio	28.78
Dividend Yield	1.28%
Profit Margin	26.86%
Quarterly Earnings Growth YOY	0.13%
Return On Equity TTM	51.14%

How to invest in Zoetis Stock (ZTS) from India?

It is very easy for Indian residents to invest directly in Zoetis from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Zoetis stock in both Indian Rupees (INR) and US Dollars (USD). Search for Zoetis or ZTS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Zoetis or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Zoetis shares which would translate to 0.005 fractional shares of Zoetis as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Zoetis, in just a few clicks!

Returns in Zoetis (ZTS) for Indian investors in Rupees

The Zoetis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Zoetis investment value today

Current value as on today

₹86,242

Returns

₹13,758

(-13.76%)

Returns from Zoetis Stock

₹18,407 (-18.41%)

Dollar Returns

₹4,649 (+4.65%)

Indian investors sentiment towards Zoetis (ZTS)

71%

Period: Jan 22, 2025 to Feb 21, 2025. Change in 30 Days versus previous period

Search interest for Zoetis Stock from India on INDmoney has increased by 71% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Zoetis Stock (ZTS Ticker)

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	3892	-51.02	0.15%

Global Institutional Holdings in Zoetis

Vanguard Group Inc
9.22%
BlackRock Inc
8.52%
State Street Corp
4.41%
State Farm Mutual Automobile Ins Co
3.57%
AllianceBernstein L.P.
3.43%
Bank of America Corp
3.20%

Analyst Recommendation on Zoetis

Buy

86%Buy

13%Hold

0%Sell

Based on 22 Wall street analysts offering stock ratings for Zoetis(by analysts ranked 0 to 5 stars)

Based on 22 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Zoetis Stock (ZTS)

What analysts predicted

Upside of 27.76%

Target:

$205.01

Current:

$160.46

Insights on Zoetis Stock (Ticker Symbol: ZTS)

Price Movement
In the last 3 months, ZTS stock has moved down by -10.9%
Decreasing Revenue
Zoetis Inc. has experienced a decline in revenue for the last two quarters. Specifically, their revenue decreased from $2.38 billion to $2.31 billion, which represents an average decrease of 3.0% per quarter.
Decreasing Net Profit
Zoetis Inc. has experienced a decline in net profit over the last two quarters. The profit decreased from $682.0 million to $581.0 million, resulting in an average decrease of 14.8% each quarter.
ZTS vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 75.4% return, outperforming this stock by 91.8%
ZTS vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 127.0% return, outperforming this stock by 144.7%
Price to Sales
Zoetis Inc. is currently valued at a Price-to-Sales Ratio of 7.7, meaning that investors are willing to pay $7.70 for every $1 of sales the company generates. In comparison, Intra-cellular Therapies, Inc. has a much higher Price-to-Sales Ratio of 21.1, indicating that investors are paying $21.10 for every $1 of sales for that company. This suggests that investors may view Zoetis Inc. as a more reasonably priced stock compared to Intra-cellular Therapies, Inc.

ZTS Zoetis Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$6.3B	↑ 7.47%
Net Income	$1.5B	↑ 5.04%
Net Profit Margin	23.96%	↓ 0.56%

	FY20	Y/Y Change
Revenue	$6.7B	↑ 6.63%
Net Income	$1.6B	↑ 9.2%
Net Profit Margin	24.54%	↑ 0.58%

	FY21	Y/Y Change
Revenue	$7.8B	↑ 16.49%
Net Income	$2.0B	↑ 24.36%
Net Profit Margin	26.2%	↑ 1.66%

	FY22	Y/Y Change
Revenue	$8.1B	↑ 3.91%
Net Income	$2.1B	↑ 3.78%
Net Profit Margin	26.16%	↓ 0.04%

	FY23	Y/Y Change
Revenue	$8.5B	↑ 5.74%
Net Income	$2.3B	↑ 10.88%
Net Profit Margin	27.43%	↑ 1.27%

	FY24	Y/Y Change
Revenue	$9.3B	↑ 8.33%
Net Income	$2.5B	↑ 6.06%
Net Profit Margin	26.86%	↓ 0.57%

	Q3 FY23	Q/Q Change
Revenue	$2.2B	↓ 1.33%
Net Income	$596.0M	↓ 11.18%
Net Profit Margin	27.71%	↓ 3.07%

	Q4 FY23	Q/Q Change
Revenue	$2.2B	↑ 2.88%
Net Income	$525.0M	↓ 11.91%
Net Profit Margin	23.72%	↓ 3.99%

	Q1 FY24	Q/Q Change
Revenue	$2.2B	↓ 1.04%
Net Income	$599.0M	↑ 14.1%
Net Profit Margin	27.35%	↑ 3.63%

	Q2 FY24	Q/Q Change
Revenue	$2.4B	↑ 7.81%
Net Income	$624.0M	↑ 4.17%
Net Profit Margin	26.43%	↓ 0.92%

	Q3 FY24	Q/Q Change
Revenue	$2.4B	↑ 1.14%
Net Income	$682.0M	↑ 9.29%
Net Profit Margin	28.56%	↑ 2.13%

	Q4 FY24	Q/Q Change
Revenue	$2.3B	↓ 2.97%
Net Income	$581.0M	↓ 14.81%
Net Profit Margin	25.08%	↓ 3.48%

	FY19	Y/Y Change
Profit	$4.3B	↑ 9.04%

	FY20	Y/Y Change
Profit	$4.6B	↑ 8.2%

	FY21	Y/Y Change
Profit	$5.5B	↑ 18.51%

	FY22	Y/Y Change
Profit	$5.6B	↑ 2.8%

	FY23	Y/Y Change
Profit	$5.8B	↑ 3.7%

	FY24	Y/Y Change
Profit	$6.5B	↑ 12.05%

	Q3 FY23	Q/Q Change
Profit	$1.5B	↓ 3.81%

	Q4 FY23	Q/Q Change
Profit	$1.4B	↓ 4.3%

	Q1 FY24	Q/Q Change
Profit	$1.5B	↑ 4.28%

	Q2 FY24	Q/Q Change
Profit	$1.7B	↑ 9.8%

	Q3 FY24	Q/Q Change
Profit	$1.7B	↑ 1.75%

	Q4 FY24	Q/Q Change
Profit	$1.6B	↓ 4.56%

	FY19	Y/Y Change
Operating Cash Flow	$1.8B	↑ 0.28%
Investing Cash Flow	$-504.0M	↓ 77.69%
Financing Cash Flow	$-951.0M	↓ 278.42%

	FY20	Y/Y Change
Operating Cash Flow	$2.1B	↑ 18.44%
Investing Cash Flow	$-572.0M	↑ 13.49%
Financing Cash Flow	$123.0M	↓ 112.93%

	FY21	Y/Y Change
Operating Cash Flow	$2.2B	↑ 4.09%
Investing Cash Flow	$-458.0M	↓ 19.93%
Financing Cash Flow	$-1.9B	↓ 1613.82%

	FY22	Y/Y Change
Operating Cash Flow	$1.9B	↓ 13.6%
Investing Cash Flow	$-883.0M	↑ 92.79%
Financing Cash Flow	$-904.0M	↓ 51.45%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$724.0M	↑ 295.63%
Investing Cash Flow	$-567.0M	↑ 608.75%
Financing Cash Flow	$-416.0M	↓ 15.79%

Zoetis Technicals Summary

Sell

Neutral

Buy

Zoetis is currently in a neutral trading position according to technical analysis indicators.

Zoetis (ZTS) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Zoetis Inc.	-5.71%	-13.3%	-20.18%	-15.85%	13.75%
Intra-cellular Therapies, Inc.	1.16%	72.56%	83.21%	142.3%	458.87%
Haleon Plc Spon Ads	5.43%	0.3%	17.72%	33.6%	33.6%
Neurocrine Biosciences Inc.	-20.88%	-23.75%	-13.47%	35.72%	19.79%
Viatris Inc.	-0.72%	-5.87%	-18.26%	-22.77%	-32.31%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Zoetis Inc.	28.78	28.78	2.77	6.15	0.51	0.15	0.01	10.64
Intra-cellular Therapies, Inc.	NA	NA	0.0	-0.71	-0.1	-0.07	NA	10.8
Haleon Plc Spon Ads	30.0	30.0	1.74	0.36	0.07	0.04	0.02	1.82
Neurocrine Biosciences Inc.	35.29	35.29	0.27	6.46	0.14	0.1	NA	26.05
Viatris Inc.	224.4	NA	0.07	2.68	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Zoetis Inc.	Buy	$70.5B	13.75%	28.78	26.86%
Intra-cellular Therapies, Inc.	Buy	$13.7B	458.87%	NA	-14.07%
Haleon Plc Spon Ads	Buy	$44.8B	33.6%	30.0	10.75%
Neurocrine Biosciences Inc.	Buy	$11.6B	19.79%	35.29	14.49%
Viatris Inc.	Hold	$13.0B	-32.31%	224.4	-5.87%

Zoetis Dividend announcements

Zoetis Dividends June, 2025
In the quarter ending June,2025. Zoetis has declared dividend of $0.50
Read More

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1950 and is headquartered in Parsippany, New Jersey.

Organization	Zoetis
Employees	13800
CEO	Ms. Kristin C. Peck
Industry	Health Technology

Management People of Zoetis

Name	Title
Ms. Kristin C. Peck	CEO & Director
Dr. Robert J. Polzer Ph.D.	Executive VP and President of Research & Development
Mr. Keith Sarbaugh	Executive VP & Chief Digital and Technology Officer
Mr. Steven Frank	Vice President of Investor Relations
Ms. Roxanne Lagano	Executive VP, General Counsel & Corporate Secretary
Ms. Julie A. Fuller	Executive VP, Chief Human Resources Officer & Global Operations
Ms. Jeannette Ferran Astorga	Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer
Mr. Nick Ashton	Executive VP and President of Global Manufacturing & Supply
Mr. Jamie Brannan	Executive VP & Chief Commercial Officer
Ms. Rimma Driscoll	Executive VP and Head of Global Strategy, Commercial & Business Development and Global BioDevices

Important FAQs about investing in ZTS Stock from India :

What is Zoetis share price today?

Zoetis share price today stands at $160.46, Open: $157.78 ; Previous Close: $157.42 ; High: $160.90 ; Low: $157.60 ; 52 Week High: $200.53 ; 52 Week Low: $144.80.

The stock opens at $157.78, after a previous close of $157.42. The stock reached a daily high of $160.90 and a low of $157.60, with a 52-week high of $200.53 and a 52-week low of $144.80.

Can Indians buy Zoetis shares?

Yes, Indians can invest in the Zoetis (ZTS) from India.

With INDmoney, you can buy Zoetis at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Zoetis at zero transaction cost.

How can I buy Zoetis shares from India?

It is very easy to buy Zoetis from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Zoetis (ZTS) be purchased?

Yes, you can buy fractional shares of Zoetis with INDmoney app.

What are the documents required to start investing in Zoetis stocks?

To start investing in Zoetis, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.